This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 500296 Submitted by lobbyist on: September 14, 2015 09:49:28 AM Accepted by Registrar on: September 14, 2015 10:24:36 AM
Designated Filer Information
Keon, James J
4120 Yonge Street Suite 409
Toronto, ON, M2P 2B8
416-223-2333
Canada
Organization Information
Canadian Generic Pharmaceutical Association (CGPA)
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.
4120 Yonge Street Suite 409
Toronto, ON, M2P 2B8
416-223-2333
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
September 14, 2015
March 12, 2016
Organization's In-House Lobbyists
Name:
Connell, Jeff
September 14, 2015
Inactivation Date:
March 28, 2016
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Support for CGPA's position in intellectual property discussions in the Trans-Pacific Partnership trade negotiations. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Minister
Lake,
Terry
Minister of Health
September 14, 2015
Minister
Wat,
Teresa
Minister Responsible for Asia Pacific Strategy and Multiculturalism
September 14, 2015
Public Agency
Health
September 14, 2015
Public Agency
Office of the Premier
September 14, 2015
Name:
Cox, Jody
September 14, 2015
Inactivation Date:
March 28, 2016
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Support for CGPA's position in respect of intellectual property protection for pharmaceutical drugs in the Trans-Pacific Partnership negotiations.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Public Agency
International Trade
September 14, 2015
Name:
Keon, James
September 14, 2015
Inactivation Date:
March 28, 2016
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Alignment of British Columbia's listing and pricing policies for generic drugs with that of the pan-Canadian National Pharmaceutical Alliance. Support for CGPA's position in intellectual property discussions in the Trans-Pacific Partnership trade negotiations. Addressing delays in listing certain generic drugs due to requirement of a Ministerial Order and discussion of alternatives.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
Minister
Lake,
Terry
Minister of Health
September 14, 2015
Minister
Wat,
Teresa
Minister Responsible for Asia Pacific Strategy and Multiculturalism
